Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1700 (2.94%) ($7.1700 - $7.1700) on Thu. Aug. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 56 | Latest Price | $7.1700(2.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLE(33%) XOP(32%) OIH(21%) PAVE(14%) UNG(49%) | Factors Impacting BCRX price | BCRX will decline at least -1.555% in a week (0% probabilities). ARKK(-49%) XLRE(-40%) EWI(-36%) XLY(-35%) XLP(-32%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.13(0.56%) | 10 Day Moving Average | $7.18(-0.14%) | 20 Day Moving Average | $7.11(0.84%) | To recent high | -19% | To recent low | 7% | Market Cap | $1.265b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |